H. Elsaleh

发表

Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.

B. Iacopetta, B. Powell, R. Soong, 2000, European journal of cancer.

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

K. Kinzler, P. Gibbs, M. Christie, 2018, Gut.

Internet use by radiation oncology patients: a pilot study

H. Elsaleh, D. Joseph, C. Duffy, 2000, The Medical journal of Australia.

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

David Joseph, Hany Elsaleh, N. Zeps, 2000, The Lancet.

Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.

B. Iacopetta, H. Elsaleh, Barry Iacopetta, 2001, Clinical colorectal cancer.

P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.

B. Iacopetta, B. Powell, H. Elsaleh, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Breast cancer survival advantage with radiotherapy

H. Elsaleh, D. Joseph, N. Spry, 2000, The Lancet.

TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value.

J. Hamdorf, B. Iacopetta, H. Elsaleh, 1999, European journal of cancer.

Pre-operative chemoradiotherapy in locally advanced rectal cancer.

H. Elsaleh, D. Joseph, P. Robbins, 1999, The Australian and New Zealand journal of surgery.

Differences in toxicity across gender in patients treated with chemoradiation for rectal cancer.

H. Elsaleh, D. Joseph, David Joseph, 2007, Australasian radiology.

A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

B. Iacopetta, H. Elsaleh, D. Joseph, 2001, British Journal of Cancer.

Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?

B. Iacopetta, B. Powell, H. Elsaleh, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ki‐ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer

B. Iacopetta, H. Elsaleh, G. Gnanasampanthan, 2001, The Journal of pathology.

P 53 Alteration and Microsatellite Instability Have Predictive Value for Survival Benefit from Chemotherapy in Stage III Colorectal Carcinoma 1

B. Iacopetta, B. Powell, H. Elsaleh, 2001 .

Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy.

B. Iacopetta, H. Elsaleh, B. Shannon, 2001, Gastroenterology.

p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon Carcinoma

B. Iacopetta, B. Powell, H. Elsaleh, 2000, Oncology.

Development of Indicators to Assess Quality of Care for Prostate Cancer.

David P. Smith, D. Roder, M. Frydenberg, 2016, European urology focus.

Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?

H. Elsaleh, C. Crane, J. Farrell, 2009, Journal of gastroenterology and hepatology.

HUMAN ENT1 IS PREDICTIVE OF RESPONSE IN PATIENTS WITH PANCREATIC CANCER TREATED WITH GEMCITABINE: RESULTS FROM THE RTOG 9704 PROSPECTIVE RANDOMIZED TRIAL

R. Abrams, J. Mackey, C. Cass, 2007 .

MISSION TO MARS: RADIATION SAFETY OR RADIATION DISASTER? SPACE TRANSIT AND MARS RADIATION EXPOSURE RISKS – THE POTENTIAL SHIELDING EFFECT OF AN INTRAVEHICULAR GRAPHENE SPACE SUIT AND A STORM SHELTER DURING SPACE TRAVEL

H. Elsaleh, T. Squire, Grant Buchanan, 2020, Journal of the Australasian Society of Aerospace Medicine.

The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC).

K. Kinzler, B. Vogelstein, P. Gibbs, 2017 .

Evidence for tumour site and gender-specific survival benefit from adjuvant chemotherapy in colorectal cancer: Molecular predictive markers come of age

B. Iacopetta, H. Elsaleh, D. Joseph, 2000 .

Microsatellite instability in colorectal cancer: prognostic, predictive or both?

B. Iacopetta, H. Elsaleh, M. van Rijnsoever, 2002, The American journal of pathology.

Tumour site, sex, and survival in colorectal cancer

B. Iacopetta, H. Elsaleh, 2000, The Lancet.

Early detection markers in Pancreas Cancer.

H. Elsaleh, J. Farrell, M. van Rijnsoever, 2005, Cancer biomarkers : section A of Disease markers.

Radiation modifiers: treatment overview and future investigations.

H. Elsaleh, J. Farrell, A. Ammar, 2006, Hematology/oncology clinics of North America.

CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.

B. Iacopetta, H. Elsaleh, D. Joseph, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Alternative cyclin D1 splice forms differentially regulate the DNA damage response.

H. Elsaleh, E. Soutoglou, E. Knudsen, 2010, Cancer research.

Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands

B. Iacopetta, H. Elsaleh, D. Joseph, 2002, Gut.

Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients.

M. Southey, H. Elsaleh, D. Venter, 2001, International journal of radiation oncology, biology, physics.

Prognostic Significance of Microsatellite Instability and Ki-ras Mutation Type in Stage II Colorectal Cancer

B. Iacopetta, H. Elsaleh, D. Joseph, 2003, Oncology.

Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach

Zhong Zheng, Yun Yen, Chandan Guha, 2016, Pancreas.

Cancer esearch or and Stem Cell Biology rnative Cyclin D 1 Splice Forms Differentially Regulate the R Damage Response

H. Elsaleh, G. Li, E. Soutoglou, 2010 .

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Adam P Dicker, Raymond Lai, John R Mackey, 2009, Gastroenterology.

The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects.

H. Withers, H. Elsaleh, M. Lieber, 2004, International journal of radiation oncology, biology, physics.

Small cell carcinoma of the vagina.

H. Elsaleh, S. Bydder, J. Thompson, 2000, Australasian radiology.

PRIMARY NON HODGKIN'S LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM

H. Elsaleh, P. Robbins, 2001 .

Choroid plexus carcinoma in an adult.

H. Elsaleh, S. Wyatt, D. Holthouse, 2001, Australasian radiology.

Disparities in radiation therapy utilization for cancer patients in Victoria

R. Milne, H. Elsaleh, G. Hanna, 2022, Journal of medical imaging and radiation oncology.

Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism.

B. Iacopetta, H. Elsaleh, D. Joseph, 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

D. Kerr, R. Lothe, V. Moreno, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?

H. Elsaleh, T. Rich, D. Yip, 2017, Chronobiology international.

Pre-Operative Chemo-Radiotherapy in Locally Advanced Rectal Cancers

H. Elsaleh, D. Joseph, P. Robbins, 1999 .

Extent of Nodal Involvement in Stage III Colorectal Carcinoma

B. Iacopetta, H. Elsaleh, G. Cserni, 2002, Diseases of the colon and rectum.

Tumour response rate alone does not reliably predict survival in people undergoing treatment for advanced colorectal cancer

H. Elsaleh, 2000 .

Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704

A. Dicker, H. Elsaleh, C. Guha, 2011, The Pharmacogenomics Journal.

Machine learning predicts cancer subtypes and progression from blood immune signatures

H. Elsaleh, B. Quah, Jason D. Price, 2022, PloS one.

Radiation Oncology Orals Presentations

H. Elsaleh, N. Haynes, J. Hagekyriakou, 2018, Journal of Medical Imaging and Radiation Oncology.

Reply: Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil

B. Iacopetta, H. Elsaleh, 2002, British Journal of Cancer.

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

E. Berns, B. Iacopetta, B. Powell, 2001, Breast Cancer Research and Treatment.

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy

Ryan L. Smith, H. Elsaleh, J. Ruben, 2021, PloS one.

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.

H. Elsaleh, J. Millar, B. Higgs, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes

Kei Yamada, H. Yamazaki, H. Elsaleh, 2022, Radiation Oncology.

Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer

H. Rui, B. Vonen, Ø. Fluge, 2012, British Journal of Cancer.

Advances in biological dosimetry

H. Elsaleh, T. Ohnesorg, A. Ivashkevich, 2017 .

Custom-designed Small Animal focal iRradiation Jig (SARJ): design, manufacture and dosimetric evaluation

Mounir Ibrahim, Jothy Selvaraj, Graham Rhall, 2020, BJR open.

P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas.

B. Iacopetta, H. Elsaleh, D. Joseph, 1999, International journal of oncology.

CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.

B. Iacopetta, H. Elsaleh, D. Joseph, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

R. Abrams, J. Mackey, C. Cass, 2009, Gastroenterology.

Pre-operative chemoradiotherapy in locally advanced rectal cancer.

H. Elsaleh, M. Levitt, David Joseph, 1999, The Australian and New Zealand journal of surgery.